Clinical trial
Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic…
NCT00276926 · University of Bologna, Other · Unknown status
Key facts
| NCT number | NCT00276926 |
|---|---|
| Title | Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias |
| Official title | Open Label Pilot Phase II Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias |
| Lead sponsor | University of Bologna, Other |
| Collaborators | Novartis Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL), Myeloproliferative Disorders |
| Intervention type | Drug |
| Interventions | STI571 |
| Start date | Mar 1, 2003 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 15, 2009 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: